The US market for medical biotechnology is one of the largest and most advanced markets in the world. The United States leads in biotechnological research and development. The favorable regulatory environment and access to capital have fostered the sector’s growth. In 2021, the US market for medical biotechnology was around USD 172 billion. By 2030, an annual growth rate of nearly 7% is expected. With almost 30% of the global market, the US represents the largest market for medical biotechnology, primarily due to increasing awareness of healthcare and the well-established manufacturing facilities of major players in the country. In addition, many well-known biotechnology and pharmaceutical companies in the US attract sponsors for the red biotechnology market to increase their national presence. Overall, this contributes to the US maintaining its leading position in the global market for medical biotechnology in the future.
Interested in learning more? Get access to the full version of the report: